Neisseria gonorrhoeae resistant to ceftriaxone and cefixime, Argentina

Emerging Infectious Diseases

Volumn 22, Issue 6, 2016, Pages 1139-1141

  Gianecini, Ricardo ^a   Oviedo, Claudia ^a   Stafforini, Graciela ^b   Galarza, Patricia ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b Hospital Interzonal Artémides Zatti   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; CASE REPORT; GENE SEQUENCE; GONORRHEA; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; TIME OF FLIGHT MASS SPECTROMETRY; YOUNG ADULT; ALLELE; ARGENTINA; BETA-LACTAM RESISTANCE; CLASSIFICATION; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION;

ALLELES; ANTI-BACTERIAL AGENTS; ARGENTINA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFIXIME; CEFTRIAXONE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA GONORRHOEAE; YOUNG ADULT;

EID: 84969132902     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2206.152091     Document Type: Letter

References (10)

1. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401-1422. http://dx.doi.org/10.2217/fmb.12.117
2. Starnino S, Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, et al. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Sex Transm Dis. 2012;39:813-821. http://dx.doi.org/10.1097/OLQ.0b013e3182631c9f
3. World Health Organization. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Geneva: The Organization; 2013 [cited 2016 Feb 27]. http://apps.who.int/iris/bitstream/10665/85343/1/9789241505840_eng.pdf
4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard, 9th ed. M07A9. Wayne (PA): The Institute; 2012.
5. Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, et al. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother. 2011;55:703-712. http://dx.doi.org/10.1128/AAC.00788-10
6. Whiley DM, Jacobsson S, Tapsall JW, Nissen MD, Sloots TP, Unemo M. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother. 2010;65:2543-2547. http://dx.doi.org/10.1093/jac/dkq377
7. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55:3538-3545. http://dx.doi.org/10.1128/AAC.00325-11
8. Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, et al. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother. 2010;65:1615-1618. http://dx.doi.org/10.1093/jac/dkq187
9. Unemo M. Current and future antimicrobial treatment of gonorrhea: The rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364.
10. Gianecini R, Oviedo C, Bardossy E, Galarza P. Evaluation of antimicrobial susceptibility and resistance in Neisseria gonorrhoeae, Argentina, 2009-2013. In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy/International Congress of Chemotherapy, San Diego, Sep 17-21, 2015. Washington (DC): American Society for Microbiology; 2015. Abstract C-672.